Meningococcal burden of disease in Argentina: 10 years epidemiologic review

Meningococcal burden of disease in Argentina: 10 years epidemiologic review

Invasive meningococcal disease (IMD) is an uncommon but serious and potentially fatal condition, mainly affecting infants. In 2017, Argentina introduced a vaccination program against serogroups A, C, W and Y (MenACWY) for infants aged 3, 5 and 15 months and adolescents aged 11 years. The objective o...

Full description

Bibliographic Details
Main Authors:	Silvina Neyro, Analia Urueña, Adriana Efron, Carolina Rancaño, Maria E. Pannunzio, Maria B. Seoane, Jorge A. Gomez, Norberto Giglio
Format:	Article
Language:	English
Published:	Taylor & Francis Group 2023-08-01
Series:	Human Vaccines & Immunotherapeutics
Subjects:	children disease burden meningococcal disease serogroups argentina
Online Access:	http://dx.doi.org/10.1080/21645515.2023.2237391

Similar Items

Proceedings of the Expert Consensus Group meeting on meningococcal serogroup B disease burden and prevention in India
by: Anand P. Dubey, et al.
Published: (2022-01-01)

A critical analysis of serogroup B meningococcal disease burden in Brazil (2001–2015): implications for public health decisions
by: Luciana Andrea Digieri Chicuto, et al.
Published: (2020-08-01)

A Review of the Epidemiology of Invasive Meningococcal Disease and Vaccination Strategies in North Africa
by: Muhamed-Kheir Taha, et al.
Published: (2021-03-01)

Transmissibility and pathogenicity of the emerging meningococcal serogroup W sequence type-11 complex South American strain: a mathematical modeling study
by: Matthieu Domenech de Cellès, et al.
Published: (2020-04-01)

The Global Meningococcal Initiative: global epidemiology, the impact of vaccines on meningococcal disease and the importance of herd protection
by: Ray Borrow, et al.
Published: (2017-04-01)

Range of Clinical Manifestations Caused by Invasive Meningococcal Disease Due to Serogroup W: A Systematic Review
by: Isabelle Bertrand-Gerentes, et al.
Published: (2023-09-01)

Cost of Illness Analysis of Invasive Meningococcal Disease Caused by Neisseria Meningitidis Serogroup B in the Netherlands—a Holistic Approach
by: Florian Zeevat, et al.
Published: (2024-02-01)

Global epidemiology of serogroup B meningococcal disease and opportunities for prevention with novel recombinant protein vaccines
by: Rodolfo Villena, et al.
Published: (2018-05-01)

Safety and immunogenicity of meningococcal (Groups A and C) polysaccharide vaccine in children 2 to 6 y of age in China: a randomized, active-controlled, non-inferiority study
by: Feng-Cai Zhu, et al.
Published: (2021-03-01)

Epidemiology of Invasive Meningococcal Disease in Colombia: A Retrospective Surveillance Database Analysis
by: Wilfrido Coronell-Rodriguez, et al.
Published: (2023-11-01)

Increase in Meningococcal Serogroup W Disease, Victoria, Australia, 2013–2015
by: Kylie S. Carville, et al.
Published: (2016-10-01)

Effectiveness of quadrivalent meningococcal conjugate vaccine against meningococcal carriage and genotype character changes: A secondary analysis of prospective cohort study in Korean military trainees
by: Young Rong Kim, et al.
Published: (2024-09-01)

Economic burden of meningococcal disease in children and adolescents in Tijuana, Mexico
by: Enrique Chacon-Cruz, et al.
Published: (2022-11-01)

Protecting UK adolescents and adults against meningococcal serogroup B disease
by: Andrew Vyse, et al.
Published: (2018-03-01)

Culture-Confirmed Invasive Meningococcal Disease in Canada, 2010 to 2014: Characterization of Serogroup B <italic toggle="yes">Neisseria meningitidis</italic> Strains and Their Predicted Coverage by the 4CMenB Vaccine
by: Raymond S. W. Tsang, et al.
Published: (2020-04-01)

Serogroup Y Meningococcal Disease, Colombia
by: Clara Inés Agudelo, et al.
Published: (2008-06-01)

Epidemiology of serogroup B invasive meningococcal disease in Ontario, Canada, 2000 to 2010
by: Dang Vica, et al.
Published: (2012-08-01)

Global Epidemiology of Meningococcal Disease-Causing Serogroups Before and After the COVID-19 Pandemic: A Narrative Review
by: Steven Shen, et al.
Published: (2024-11-01)

Parental awareness and utilization of meningococcal serogroup B vaccines in the United States
by: Amit Srivastava, et al.
Published: (2020-07-01)

Meningococcal Disease in South Africa, 1999–2002
by: Garry B. Coulson, et al.
Published: (2007-02-01)

[Meningococcal meningitis: a case of serogroup W in an underage migrant]
by: Silvia Dari, et al.
Published: (2017-06-01)

Recognition of the epidemiological significance of Neisseria meningitidis capsular serogroup W135 in the Rio de Janeiro region, Brazil
by: David E Barroso, et al.
Published: (2007-09-01)

Fatal meningococcal meningitis in a HIV-infected patient caused by serogroup C Neisseria meningitidis belonging to the non-hypervirulent clonal complex ST-60 (cc60)
by: Claudia Ferreira de Andrade, et al.

Trajectory of serogroups causing Invasive Meningococcal Disease in Santa Catarina state, Brazil (2007–2019)
by: Ricardo Becker Feijo, et al.
Published: (2020-07-01)

Serogroup B Invasive Meningococcal Disease in Older Adults Identified by Genomic Surveillance, England, 2022–2023
by: Emily Loud, et al.
Published: (2024-05-01)

Economic Burden of Invasive Meningococcal Infection in Children in the Republic of Belarus
by: E. N. Sergienko, et al.
Published: (2024-01-01)

Emergency Meningococcal ACWY Vaccination Program for Teenagers to Control Group W Meningococcal Disease, England, 2015–2016
by: Helen Campbell, et al.
Published: (2017-07-01)

Prevalence of Neisseria meningitidis serogroups in invasive meningococcal disease in China, 2010 - 2020: a systematic review and meta-analysis
by: Juan Xu, et al.
Published: (2022-11-01)

Continuing Effectiveness of Serogroup A Meningococcal Conjugate Vaccine, Chad, 2013
by: Kadidja Gamougam, et al.
Published: (2015-01-01)

Triplex Real-Time PCR without DNA Extraction for the Monitoring of Meningococcal Disease
by: Melissa J. Whaley, et al.
Published: (2018-08-01)

Sex, Age, and Race Effects on Immunogenicity of MenB-FHbp, A Bivalent Meningococcal B Vaccine: Pooled Evaluation of Clinical Trial Data
by: Johannes Beeslaar, et al.
Published: (2020-07-01)

Meningococcal Urethritis: an additional Source of Meningococcal Disease?
by: N. N. Kostyukova, et al.
Published: (2020-07-01)

Impact of serogroup A meningococcal conjugate vaccine for Africa
by: James M. Stuart
Published: (2018-05-01)

Invasive meningococcal disease epidemiology and vaccination strategies in four Southern European countries: a review of the available data
by: Irini Zografaki, et al.
Published: (2023-12-01)

Case−Control Study of Risk Factors for Meningococcal Disease in Chile
by: Andrea Olea, et al.
Published: (2017-07-01)

Serogroup B Meningococcal Disease Vaccine Recommendations at a University, New Jersey, USA, 2016
by: Heidi M. Soeters, et al.
Published: (2017-05-01)

The important lessons lurking in the history of meningococcal epidemiology
by: Ray Borrow, et al.
Published: (2024-12-01)

Characteristics of YouTube videos about the meningococcal B vaccine (4CMenB)
by: Ignacio Hernández-García, et al.
Published: (2020-10-01)

Cost calculator for mass vaccination response to a US college campus outbreak of serogroup B meningococcal disease
by: Elizabeth M. La, et al.
Published: (2019-04-01)

Prediction by genetic MATS of 4CMenB vaccine strain coverage of invasive meningococcal serogroup B isolates circulating in Taiwan between 2003 and 2020
by: Alessandro Muzzi, et al.
Published: (2024-06-01)